These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 19553814)

  • 1. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic cancers.
    Blair AR; Casas CM
    Prim Care; 2009 Mar; 36(1):115-30, ix. PubMed ID: 19231605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective.
    Amit A; Schink J; Reiss A; Lowenstein L
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):1-21, vii. PubMed ID: 21419325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
    Schwarz JK; Grigsby PW; Dehdashti F; Delbeke D
    J Nucl Med; 2009 May; 50 Suppl 1():64S-73S. PubMed ID: 19380409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
    Petru E; Lück HJ; Stuart G; Gaffney D; Millan D; Vergote I;
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):69-74. PubMed ID: 19195765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic malignancies.
    Whitcomb BP
    Surg Clin North Am; 2008 Apr; 88(2):301-17, vi. PubMed ID: 18381115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the primary physician in the detection and treatment of gynecologic cancer.
    Fuller AF
    Prim Care; 1981 Mar; 8(1):111-29. PubMed ID: 6911754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge of tumor markers and the psychological consequences of tumor marker sampling in patients with gynecologic cancers.
    Mayerhofer K; Bodner K; Aktas C; Schindl M; Kaider A; Leodolter S; Joura EA; Kainz C
    Anticancer Res; 2000; 20(2B):1281-4. PubMed ID: 10810435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of plasma ribonuclease as a marker for gynecologic tumors and breast tumors].
    Kraus H; Deinert S
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):20-2. PubMed ID: 3956957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations.
    Salani R; Backes FJ; Fung MF; Holschneider CH; Parker LP; Bristow RE; Goff BA
    Am J Obstet Gynecol; 2011 Jun; 204(6):466-78. PubMed ID: 21752752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of colposcopy in diagnosing recurrent gynecologic malignancies].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 1990 Nov; 12(6):438-40. PubMed ID: 2076640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression in the female genital tract and its value in diagnosis.
    O'Neill CJ; McCluggage WG
    Adv Anat Pathol; 2006 Jan; 13(1):8-15. PubMed ID: 16462152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
    Schwartz PE; Cracchiolo BM; Cole LA
    Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging in the management of gynecologic malignancies.
    Lai CH; Lin G; Yen TC; Liu FY
    Gynecol Oncol; 2014 Oct; 135(1):156-62. PubMed ID: 25065896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of PET Imaging in Gynecologic Radiation Oncology.
    Rao YJ; Grigsby PW
    PET Clin; 2018 Apr; 13(2):225-237. PubMed ID: 29482751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology of voided urine in the diagnosis of gynecologic malignancy.
    Smith P; Crozier EH
    Obstet Gynecol; 1973 Mar; 41(3):440-2. PubMed ID: 4688260
    [No Abstract]   [Full Text] [Related]  

  • 19. Gynecologic malignancies in older women.
    Mirhashemi R; Nieves-Neira W; Averette HE
    Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.